Thrivent Financial for Lutherans lessened its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 97.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 19,948 shares of the health services provider's stock after selling 774,647 shares during the quarter. Thrivent Financial for Lutherans' holdings in Maximus were worth $1,858,000 as of its most recent filing with the SEC.
Other hedge funds have also made changes to their positions in the company. Quadrature Capital Ltd acquired a new stake in Maximus during the first quarter worth approximately $238,000. Price T Rowe Associates Inc. MD boosted its position in shares of Maximus by 6.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 38,100 shares of the health services provider's stock worth $3,197,000 after purchasing an additional 2,322 shares in the last quarter. Tidal Investments LLC raised its stake in shares of Maximus by 238.9% during the 1st quarter. Tidal Investments LLC now owns 12,763 shares of the health services provider's stock worth $1,071,000 after buying an additional 8,997 shares during the last quarter. Virtu Financial LLC raised its stake in shares of Maximus by 16.4% during the 1st quarter. Virtu Financial LLC now owns 3,610 shares of the health services provider's stock worth $303,000 after buying an additional 508 shares during the last quarter. Finally, LRI Investments LLC acquired a new position in Maximus in the 1st quarter valued at about $93,000. Institutional investors and hedge funds own 97.21% of the company's stock.
Insiders Place Their Bets
In related news, insider Michelle F. Link sold 1,363 shares of the firm's stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the transaction, the insider now owns 6,567 shares of the company's stock, valued at $607,841.52. This trade represents a 17.19 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.40% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Separately, StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a report on Thursday.
Check Out Our Latest Stock Report on MMS
Maximus Stock Up 2.8 %
Shares of MMS traded up $2.00 during trading on Friday, reaching $74.50. The company's stock had a trading volume of 707,093 shares, compared to its average volume of 409,477. The company has a fifty day moving average of $86.81 and a two-hundred day moving average of $87.64. Maximus, Inc. has a twelve month low of $71.75 and a twelve month high of $93.97. The company has a market cap of $4.49 billion, a price-to-earnings ratio of 14.50 and a beta of 0.77. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59.
Maximus Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Saturday, November 30th. Investors of record on Friday, November 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.61%. The ex-dividend date of this dividend is Friday, November 15th. Maximus's dividend payout ratio is currently 24.00%.
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.